Secretin

Category
peptide
Half-Life (t½)
IV: 4m
Formula
C130H219N43O42
Molecular Weight
3056.4 g/mol
PubChem CID
16129665
Aliases
Secreflo, ChiRhoStim, Human synthetic secretin

Pharmacological Mechanism

27-residue peptide secreted by duodenal S-cells in response to gastric acid reaching the duodenum. Activates secretin receptor (Gs-coupled) on pancreatic duct cells → bicarbonate + water secretion; also stimulates biliary duct bicarbonate output and modestly inhibits gastric acid. Used diagnostically: (1) secretin-stimulation test to assess pancreatic exocrine reserve (chronic pancreatitis, cystic fibrosis); (2) gastrinoma stimulation — paradoxical gastrin rise ≥ 110 pg/mL within 10 min confirms Zollinger-Ellison. Very short plasma t½ (~3 min) mandates IV bolus.

Half-Life & Elimination Curve (IV: 4m)

100%50%25%12.5%0%0h0×t½4m1×t½8m2×t½12m3×t½16m4×t½20m5×t½0×t½ (0h): 100% remaining1×t½ (4m): 50% remaining2×t½ (8m): 25% remaining3×t½ (12m): 12.5% remaining4×t½ (16m): 6.3% remaining5×t½ (20m): 3.1% remaining
Elimination (IV)
  • 0×t½0h100%
  • 1×t½4m50%
  • 2×t½8m25%
  • 3×t½12m12.5%
  • 4×t½16m6.3%
  • 5×t½20m3.1%
Elimination t½4m (IV)
Rate Constant (ke)10.3 h⁻¹
97% Washout (5×t½)20m

Dosing Guidelines

Pharmacokinetic Parameters

Pathways It Modulates

Target Organ Systems

Chemical Structure & Identifiers

References